Status:
UNKNOWN
Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly
Lead Sponsor:
Indonesia University
Conditions:
Frail Elderly Syndrome
Elderly Infection
Eligibility:
All Genders
60+ years
Phase:
PHASE4
Brief Summary
Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In eld...
Detailed Description
This study consist of 2 designs. First is in vitro study to investigate the effect of alfacalcidol supplementation to IL-6, IL-10 and IFN gamma regulation in Peripheral Blood Mononuclear Cells (PBMC) ...
Eligibility Criteria
Inclusion
- Elderly age more than 60
- Willing to join research
Exclusion
- In acute infection
- Using NSAID or steroid
- Liver failure
- Hypercalcemia
Key Trial Info
Start Date :
January 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2017
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03292744
Start Date
January 10 2017
End Date
December 15 2017
Last Update
September 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo National Hospital
Jakarta, Indonesia